They Just Don't Get...
Health Care: Health Services
Baxter International Inc. (BAX: NYSE)
$50.06 -0.11 | -0.22%
06/04/12 - 04:01 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 12.70 | 15.40 | 17.70 |
| P/E High - Last 5 Yrs | 25.90 | 49.90 | 67.70 |
| P/E Low - Last 5 Yrs | 12.30 | 15.50 | 12.50 |
| Beta | 0.51 | 0.77 | 0.98 |
| Price to Sales (TTM) | 1.99 | 1.97 | 1.42 |
| Price to Book (MRQ) | 4.15 | 2.14 | 2.41 |
| Price to Tangible Book (MRQ) | 8.41 | 7.49 | 5.08 |
| Price to Cash Flow (TTM) | 9.50 | 10.50 | 9.80 |
| Price to Free Cash Flow (TTM) | 106.90 | 58.60 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 2.70 | 1.10 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | 2.10 | 1.00 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | 11.35 | 8.98 | -0.76 |
| Payout Ratio (TTM) | 33.00 | 17.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 3.20 | 10.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 8.20 | -11.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 4.88 | 12.06 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | 3.20 | 8.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | 3.20 | 8.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | 6.67 | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 40.77 | 6.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 0.90 | 1.80 | 1.10 |
| Current Ratio (MRQ) | 1.70 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.66 | 0.32 | 0.82 |
| Total Debt to Equity (MRQ) | 0.77 | 0.34 | 0.96 |
| Interest Coverage (TTM) | 31.90 | 11.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 55.50 | 59.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 54.70 | 59.90 | 47.70 |
| EBITD Margin (TTM) | 25.60 | 23.80 | 18.90 |
| EBITD - 5 Yr Avg | 24.29 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 20.10 | 15.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 19.10 | 11.90 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.16 | 0.13 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 15.20 | 8.70 | 7.00 |
| Return on Assets (TTM) | 11.90 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | 11.30 | 5.20 | 2.50 |
| Return on Investment (TTM) | 20.10 | 10.20 | 7.90 |
| Return on Investment - 5 Yr Avg | 18.40 | 7.20 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 288,598.00 | 296,359.00 | 449,376.00 |
| Net Income/Employee (TTM) | 46,227.00 | 40,294.00 | 39,003.00 |
| Receivable Turnover (TTM) | 5.90 | 6.00 | 7.60 |
| Inventory Turnover (TTM) | 2.40 | 2.90 | 8.30 |
| Asset Turnover (TTM) | 0.80 | 0.60 | 0.40 |
Portfolios with BAX
- Portfolio NameUser Type
- ProJohn Paulson
- ContributorMost-Searched Stocks for th...
- ContributorTop-Yielding Health Service...
- ProBill Frels - Mairs & Power
- ProHighbridge Capital Management
- ProFarallon Capital Management
- UserDividend Income 2011-11-23
- ProJohn Buckingham - Al Frank ...
- ContributorDividend Stocks for the Wee...
- Contributor9 Stocks With Low Volatilit...
Latest BAX Headlines from TheStreet
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.25.12 | 05:05 pm
- 6 Low-Yield Dividend Captures 05.18.12 | 11:05 am
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.11.12 | 04:05 pm
- 'Mad Money' Lightning Round: Devon's Worth More 04.19.12 | 07:04 pm
- Baxter International's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.19.12 | 02:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 06:04 pm
- Mattel, Endocyte, Ivanhoe Are Market Movers 04.16.12 | 05:04 pm
- 7 Hot Stocks on Traders' Radars 04.16.12 | 03:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 01:04 pm
- 'Mad Money' Lightning Round: Bullish on Baxter 03.27.12 | 07:03 pm
Press Releases for BAX
- Baxter Announces Collaboration With Chatham Therapeutics For Factor IX Hemophilia B Gene Therapy Treatment - Business Wire 06.04.12 | 09:06 am
- Baxter To Present At William Blair & Company 32nd Annual Growth Stock Conference - Business Wire 05.30.12 | 04:05 pm
- Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control In Trials Of Diabetics Undergoing Dialysis - Business Wire 05.25.12 | 03:05 am
- Baxter To Present At Goldman Sachs 33rd Annual Global Healthcare Conference - Business Wire 05.23.12 | 04:05 pm
- Baxter Announces ADVATE Approval In China For The Treatment Of Hemophilia A - Business Wire 05.16.12 | 09:05 am
- Baxter Declares Quarterly Dividend - Business Wire 05.07.12 | 04:05 pm
- Baxter To Present At Bank Of America Merrill Lynch 2012 Healthcare Conference - Business Wire 05.02.12 | 04:05 pm
- Leading Health Economist Mark V. Pauly, Ph.D., Named 2012 Recipient Of The Willam B. Graham Prize For Health Services Research - Business Wire 05.01.12 | 09:05 am
- Baxter Completes Purchase Of Sigma International - Business Wire 04.26.12 | 08:04 am
- Baxter To Present At Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference - Business Wire 04.24.12 | 04:04 pm
Partner Headlines for BAX
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- Stock Analysts Upgraded or Downgraded These Shares on Jun 1st - Wall St. Cheat Sheet 06.01.12 | 04:06 am
- UPDATE: Citi Lowers Baxter's PT - Benzinga 04.20.12 | 09:04 am
- Notable Options Activity in BAX - Benzinga 04.16.12 | 01:04 pm
- Baxter International Inc.: Worth A Look - Seeking Alpha 03.12.12 | 09:03 am
- Haemonetics Reaffirmed at Neutral - Analyst Blog - Zacks 03.02.12 | 06:03 pm
- Boston Scientific Offers Investors Huge Valuation Upside - Seeking Alpha 02.29.12 | 09:02 am
- Significant Upside Of About 25% For Baxter, Covidien - Seeking Alpha 02.24.12 | 05:02 pm
- Mylan Looks To Reap A Harvest Of Patent Expirations - Seeking Alpha 02.22.12 | 09:02 am
- Building A Capital Preservation And Income Portfolio, Part 8 - Seeking Alpha 02.17.12 | 04:02 pm
